SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2727JAK2 features extensively in this article, but no mention of Jakafi? bloomberg.quantman-2/15/2012
2726EULAR...... eular.org Expecting early data from "050" phase 2b to mscaram(o)uche-2/15/2012
2725Sounds like he found something unrelated to incy and spilled at yahoo? I'vescaram(o)uche-2/15/2012
2724How to interpret this news item? According to namxorex on the YMB, posted 2/11,D.Lu-2/14/2012
2723Ownership change reports Form SC 13G for 5.06% BlackRock Inc. Form SC 13G/A ftnsaf-2/10/2012
2722DeSchutter exercises options for 65K shares and keeps them. Some to expire in 20scaram(o)uche-1/31/2012
2721Thanks, Sales. Errrr..... Jim. :-)scaram(o)uche-1/25/2012
2720From the NVS quarterly report, INCY relevant (of course!), from novartis.com 1)Biotech Jim-1/25/2012
2719That will do. :-)scaram(o)uche-1/24/2012
2718Motley Fool makes the case for INCY as a buyout target: beta.fool.com Cheers, tuck-1/24/2012
2717>>LifeSci Advisors Publishes JAKAFI Survey Results Last update: 1/24/2012tuck-1/24/2012
2716Proc Natl Acad Sci U S A. 2011 Dec 27. [Epub ahead of print] TANK-binding kinascaram(o)uche-12/29/2011
2715finance.yahoo.com Pfizer Announces FDA Acceptance For Review Of New Drug Applicscaram(o)uche-12/20/2011
2714Depends on the cytochrome P450 enzyme (CYP) that the live uses to clear tofacitiBiotech Jim-12/15/2011
2713It means that 050 is pissed out, rather than being processed by liver enzymes. Tscaram(o)uche-12/14/2011
2712from today's oppenheimer healthcare conference re: 050 : tofacitinib is clsoftware salesperson-12/14/2011
2711dose ranging, psoriasis..... clinicaltrials.govscaram(o)uche-12/13/2011
2710at it again, he's now at the YMI breakfast....... BiotechStockRsrBiotechStscaram(o)uche-12/13/2011
2709"about 80% of patients" :-) Big-time prepared for this session.scaram(o)uche-12/12/2011
2708 BiotechStockRsr: MDACC presentation of ruxolitinib comparing their pts and resscaram(o)uche-12/12/2011
2707<i>YM Bio's Myelofibrosis Drug Is For Real</i> thestreet.comscaram(o)uche-12/12/2011
2706adamfeuersteinAdam Feuerstein $YMI '387 spleen response decreased but anscaram(o)uche-12/12/2011
2705150 mg bid (29%, elevated hemoglobin) makes that 300 mg qd transfusion independescaram(o)uche-12/12/2011
2704I can't confirm, of course...... BiotechStockRsrBiotechStockResearch 90scaram(o)uche-12/12/2011
2703BiotechStockRsrBiotechStockResearch SB1518 n=34 1/9 pts transfusion dependscaram(o)uche-12/12/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News